Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection

被引:31
|
作者
Iwasaki, Jua [1 ]
Smith, Wendy-Anne [1 ]
Khoo, Siew-Kim [2 ]
Bizzintino, Joelene [2 ]
Zhang, Guicheng [2 ,3 ]
Cox, Des W. [2 ]
Laing, Ingrid A. [2 ]
Le Souef, Peter N. [2 ]
Thomas, Wayne R. [1 ]
Hales, Belinda J. [1 ,2 ]
机构
[1] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
[2] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia
[3] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia
基金
英国医学研究理事会;
关键词
Human rhinovirus; VP1; IgG(1) antibody; asthma exacerbation; children; VIRAL-INFECTIONS; YOUNG-CHILDREN; T-CELLS; RESPONSES; VIRUSES; IMMUNOPATHOLOGY; ASSOCIATION; CHILDHOOD; RELEVANCE; COMMUNITY;
D O I
10.1016/j.jaci.2014.03.014
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Asthma exacerbations are associated with human rhinovirus (HRV) infections, and more severe exacerbations are associated with HRV-C. We have previously shown that the HRV-C-specific antibody response is low in healthy adult sera and that most of the antibody to HRV-C is cross-reactive with HRV-A. Objectives: To compare the antibody response to each HRV species in asthmatic and nonasthmatic children in whom the type of HRV infection was known. Methods: Total and specific IgG(1) binding to HRV viral capsid protein antigens of HRV-A, -B, and -C were tested in the plasma from nonasthmatic children (n=47) and children presenting to the emergency department with asthma exacerbations (n=96). HRV, found in most of the children at the time of their exacerbation (72%), was analyzed using molecular typing. Results: Asthmatic children had higher antibody responses to HRV. The titers specific to HRV-A, and to a lesser extent HRV-B, were higher than in nonasthmatic controls. The species-specific responses to HRV-C were markedly lower than titers to HRV-A and HRV-B in both asthmatic and nonasthmatic children (P<.001). The titers both at presentation and after convalescence were not associated with the HRV genotype detected during the exacerbation. Conclusions: The higher total anti-HRV antibody titers of asthmatic children and their higher anti-HRV-A and -B titers show their development of a heightened antiviral immune response. The low species-specific HRV-C titers found in all groups, even when the virus was found, point to a different and possibly less efficacious immune response to this species.
引用
收藏
页码:25 / +
页数:9
相关论文
共 50 条
  • [21] Rhinovirus infection and asthma symptoms in a longitudinal cohort of Australian children
    Stelzer-Braid, Sacha
    Willenborg, Christiana
    Toelle, Brett
    Garden, Frances
    Jaffe, Adam
    Strachan, Roxanne
    Belessis, Yvonne
    Oliver, Brian
    Reddel, Helen
    Marks, Guy
    Rawlinson, William
    Tovey, Euan
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [22] Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis
    Shah, Amna
    Connelly, Michael
    Whitaker, Paul
    McIntyre, Chloe
    Etherington, Christine
    Denton, Miles
    Hale, Anthony
    Harvala, Heli
    Simmonds, Peter
    Peckham, Daniel G.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) : 1748 - 1751
  • [23] Rhinovirus-Induced Exacerbations of Asthma How Is the β2-Adrenoceptor Implicated?
    Trian, Thomas
    Moir, Lyn M.
    Ge, Qi
    Burgess, Janette K.
    Kuo, Curtis
    King, Nicholas J. C.
    Reddel, Helen K.
    Black, Judith L.
    Oliver, Brian G.
    McParland, Brent E.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2010, 43 (02) : 227 - 233
  • [24] Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia
    Peltola, V.
    Waris, M.
    Kainulainen, L.
    Kero, J.
    Ruuskanen, O.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (07) : E322 - E327
  • [25] Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations
    Kloepfer, Kirsten M.
    Lee, Wai Ming
    Pappas, Tressa E.
    Kang, Theresa J.
    Vrtis, Rose F.
    Evans, Michael D.
    Gangnon, Ronald E.
    Bochkov, Yury A.
    Jackson, Daniel J.
    Lemanske, Robert F., Jr.
    Gern, James E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (05) : 1301 - U504
  • [26] Clinical correlates of rhinovirus infection in preschool asthma
    Jartti, Tuomas
    Liimatainen, Unna
    Xepapadaki, Paraskevi
    Vahlberg, Tero
    Bachert, Claus
    Finotto, Susetta
    Kowalski, Marek L.
    Sobanska, Anna
    Lukkarinen, Heikki
    Pasioti, Maria
    Vuorinen, Tytti
    Zhang, Nan
    Zimmermann, Theodor
    Papadopoulos, Nikolaos G.
    ALLERGY, 2021, 76 (01) : 247 - 254
  • [27] Distinction between rhinovirus-induced acute asthma and asthma-augmented influenza infection
    Guibas, G. V.
    Tsolia, M.
    Christodoulou, I.
    Stripeli, F.
    Sakkou, Z.
    Papadopoulos, N. G.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (05): : 536 - 543
  • [28] LATE-BREAKING ABSTRACT: Rhinovirus species and specific antibody response in preschool children with acute wheeze
    Stenberg-Hammar, Katarina
    Niespodziana, Katarzyna
    Soderhall, Cilla
    James, Anna
    Konradsen, Jon R.
    Melen, Erik
    van Hage, Marianne
    Valenta, Rudolf
    Hedlin, Gunilla
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus
    Saraya, Takeshi
    Kurai, Daisuke
    Ishii, Haruyuki
    Ito, Anri
    Sasaki, Yoshiko
    Niwa, Shoichi
    Kiyota, Naoko
    Tsukagoshi, Hiroyuki
    Kozawa, Kunihisa
    Goto, Hajime
    Takizawa, Hajime
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [30] Effects of treatment with corticosteroids on human rhinovirus-induced asthma exacerbations in pediatric inpatients: a prospective observational study
    Kan-o, Keiko
    Washio, Yasuyoshi
    Oki, Takeshi
    Fujimoto, Tsuguto
    Ninomiya, Takahito
    Yoshida, Makoto
    Fujita, Masaki
    Nakanishi, Yoichi
    Matsumoto, Koichiro
    BMC PULMONARY MEDICINE, 2023, 23 (01)